Top Story

Platelet transfusions associated with increased risk for death in HIT, TTP

January 27, 2015

Platelet transfusions are frequently used in patients with thrombotic thrombocytopenic purpura, immune thrombocytopenic purpura and heparin-induced thrombocytopenia, according to study results.

However, use of platelet transfusions in patients with thrombotic thrombocytopenic purpura (TTP) and heparin-induced thrombocytopenia (HIT) was associated with an increased risk for arterial thrombosis and mortality, results showed.

Breaking News

FDA approves Triferic for iron replacement in patients with chronic kidney disease

January 26, 2015
The FDA today approved Triferic to treat iron loss in patients with chronic kidney disease who are on dialysis, according to the drug’s manufacturer.Triferic…
In the Journals

Normal D-dimer levels after anticoagulant therapy may indicate lower recurrence of VTE

January 21, 2015
Women with normal D-dimer levels after anticoagulant treatment for a first unprovoked venous thromboembolism may have a low enough recurrence risk to justify stopping…
Meeting News Coverage

Study: Joint symptoms likely at diagnosis of hemochromatosis

January 20, 2015
Joint symptoms in the hand, wrist or other location were highly prevalent at the time of diagnosis of hemochromatosis, according to research presented at the American…
CME CNE
Low Risk AAMDS

Treatment Decision-Making through the Spectrum of MDS:
Case 1 Low Risk MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain MDS…
More »
Meeting News Coverage Video
Lowering Factor XI levels effective in prevention of venous thrombosis

Lowering Factor XI levels effective in prevention of venous thrombosis

December 11, 2014
SAN FRANCISCO – A late-breaking abstract presented at the ASH Annual Meeting and Exposition identified a novel…
More »
CME CNE
High Risk AAMDS

Treatment Decision-Making through the Spectrum of MDS:
Case 2 High Risk MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain to…
More »
Aaron Tobian, MD, PhD In the Journals

Platelet transfusions associated with increased risk for death in HIT, TTP

January 27, 2015
Platelet transfusions are frequently used in patients with thrombotic thrombocytopenic purpura, immune thrombocytopenic purpura and heparin-induced…
Breaking News

FDA approves Triferic for iron replacement in patients with chronic kidney disease

January 26, 2015
The FDA today approved Triferic to treat iron loss in patients with chronic kidney disease who are on dialysis, according to the drug’s…
In the Journals

Normal D-dimer levels after anticoagulant therapy may indicate lower recurrence of VTE

January 21, 2015
Women with normal D-dimer levels after anticoagulant treatment for a first unprovoked venous thromboembolism may have a low enough recurrence risk to…
Meeting News Coverage

Study: Joint symptoms likely at diagnosis of hemochromatosis

January 20, 2015
Joint symptoms in the hand, wrist or other location were highly prevalent at the time of diagnosis of hemochromatosis, according to research…
Jeffrey L. Carson, MD In the Journals

Liberal blood transfusion did not increase mortality risk in patients with heart disease

January 15, 2015
A liberal blood transfusion strategy did not affect mortality compared with a restrictive transfusion strategy among high-risk elderly patients with…
Meeting News Coverage

Secondary thromboprophylaxis with rivaroxaban for VTE safe in patients with APS

January 14, 2015
Patients with antiphospholipid syndrome who had previous venous thromboembolism events had no further events or bleeding incidents for 6 to 24 months…
In the Journals

Most blood clot treatments demonstrate similar efficacy, safety

January 14, 2015
Clinicians and patients have several anticoagulant options in the treatment of venous thromboembolism, and results from a Canadian study showed there…
Meeting News Coverage

Patients with APS not taking anticoagulants at higher risk for thrombotic events

January 13, 2015
Patients with antiphospholipid syndrome who did not receive or were withdrawn from anticoagulation therapies had up to a 40% higher risk of having a…
Jai N. Patel, PharmD In the Journals

Bevacizumab not significantly associated with VTE risk in patients with prostate cancer

January 12, 2015
Bevacizumab was significantly associated with an increased risk for arterial thromboembolism among patients with prostate cancer but was not…
Institution Notes

ASH awards seven Bridge Grant awards

January 9, 2015
ASH presented Bridge Grant awards to seven researchers.The 1-year, $150,000 awards provide critical interim support for hematology research proposals…
More Headlines »
morganatic-roan
morganatic-roan